Real‐world progression, treatment, and survival outcomes during rapid adoption of immunotherapy for advanced non–small cell lung cancer-Reference-Cited by-同舟云学术

Real‐world progression, treatment, and survival outcomes during rapid adoption of immunotherapy for advanced non–small cell lung cancer

Published:2019-08-05 Issue:22 Volume:125 Page:4019-4032
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Khozin Sean¹,Miksad Rebecca A.²^ORCID,Adami Johan²,Boyd Mariel²,Brown Nicholas R.²,Gossai Anala²,Kaganman Irene²,Kuk Deborah²,Rockland Jillian M.²,Pazdur Richard¹,Torres Aracelis Z.²,Zhi Jizu¹,Abernethy Amy P.²^ORCID

Affiliation:

1. US Food and Drug Administration Silver Spring Maryland

2. Flatiron Health, Inc New York New York

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32383

Reference31 articles.

1. Real-World Evidence — What Is It and What Can It Tell Us?

2. Use of Electronic Health Record Data for Quality Reporting

3. Generating real‐world tumor burden endpoints from electronic health record data: comparison of RECIST, radiology‐anchored, and clinician‐anchored approaches for abstracting real‐world progression in non‐small cell lung cancer [published online May 28, 2019];Griffith SD;Adv Ther

4. Real-World Outcomes of Patients with Metastatic Non-Small Cell Lung Cancer Treated with Programmed Cell Death Protein 1 Inhibitors in the Year Following U.S. Regulatory Approval

5. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pan-tumor validation of a NGS fraction-based MSI analysis as a predictor of response to Pembrolizumab;npj Precision Oncology;2024-09-14

2. The association between toxicity and efficacy of immune checkpoint inhibitors in older adults with NSCLC;Immunotherapy;2024-09-13

3. Impact of pembrolizumab treatment duration on overall survival and prognostic factors in advanced non-small cell lung cancer: a nationwide retrospective cohort study;The Lancet Regional Health - Europe;2024-08

4. Future of Cancer Treatment Guidelines: Integrating Real-World Insights for Equitable Cancer Care;JCO Clinical Cancer Informatics;2024-06

5. The real-world treatment characteristic and efficacy of immune checkpoint inhibitors in non-small cell lung cancer: Data from a retrospective cohort study;International Immunopharmacology;2024-06